CCI vs ENVB · P/E 40, rev $6.57B vs $3.3M cap
Crown Castle (CCI) versus Enveric Biosciences Inc (ENVB) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Enveric Biosciences Inc (ENVB) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
ENVB does not have a complete income-statement cache yet.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. ENVB currently screens at market cap $3.3M.
Not investment advice. Open the CCI and ENVB stock pages for the full models.
Not investment advice.